W Whiteley



This review is based on Dr Whiteley’s Croom Lecture at the Trainees and Members’ Symposium on 22 October 2010.

Blood biomarkers are useful for the management of many diseases and could be useful for doctors caring for stroke patients, if they accurately predicted a diagnosis or recurrence of stroke. In a series of studies, we systematically reviewed the blood biomarker literature in stroke, determined the performance of existing blood biomarkers for the diagnosis of stroke and examined the value of markers of inflammation to predict recurrent stroke and myocardial infarction.

Keywords  Biomarker, diagnosis, prognosis, stroke

Declaration of Interests Dr Whiteley was supported by a Clinical Academic Training Fellowship (CAF/06/30) from the Chief Scientist’s Office and is now funded by a Clinician Scientist Fellowship from the UK Medical Research Council (G0902303).